Stock Scorecard
Stock Summary for Heron Therapeutics Inc (HRTX) - $2.11 as of 5/12/2025 3:19:05 PM EST
Total Score
7 out of 30
Safety Score
27 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HRTX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HRTX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HRTX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HRTX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HRTX (27 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 2 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HRTX
Financial Details for HRTX
Company Overview |
|
|---|---|
| Ticker | HRTX |
| Company Name | Heron Therapeutics Inc |
| Country | USA |
| Description | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 2.11 |
| Price 4 Years Ago | 9.13 |
| Last Day Price Updated | 5/12/2025 3:19:05 PM EST |
| Last Day Volume | 2,695,316 |
| Average Daily Volume | 1,740,889 |
| 52-Week High | 3.93 |
| 52-Week Low | 1.04 |
| Last Price to 52 Week Low | 102.88% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 30.10 |
| Sector PE | 47.92 |
| 5-Year Average PE | 25.17 |
| Free Cash Flow Ratio | 16.23 |
| Industry Free Cash Flow Ratio | 18.49 |
| Sector Free Cash Flow Ratio | 30.82 |
| Current Ratio Most Recent Quarter | 2.40 |
| Total Cash Per Share | 0.13 |
| Book Value Per Share Most Recent Quarter | -0.19 |
| Price to Book Ratio | 12.60 |
| Industry Price to Book Ratio | 35.42 |
| Sector Price to Book Ratio | 27.83 |
| Price to Sales Ratio Twelve Trailing Months | 2.17 |
| Industry Price to Sales Ratio Twelve Trailing Months | 89.39 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.47 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 152,564,000 |
| Market Capitalization | 321,910,040 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.55% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 87.72% |
| Reported EPS 12 Trailing Months | -0.05 |
| Reported EPS Past Year | 0.01 |
| Reported EPS Prior Year | -0.09 |
| Net Income Twelve Trailing Months | -7,785,000 |
| Net Income Past Year | -13,580,000 |
| Net Income Prior Year | -110,559,000 |
| Quarterly Revenue Growth YOY | 12.20% |
| 5-Year Revenue Growth | -0.23% |
| Operating Margin Twelve Trailing Months | 8.11% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 19,269,000 |
| Total Cash Past Year | 25,802,000 |
| Total Cash Prior Year | 28,677,000 |
| Net Cash Position Most Recent Quarter | -155,697,000 |
| Net Cash Position Past Year | -148,924,000 |
| Long Term Debt Past Year | 174,726,000 |
| Long Term Debt Prior Year | 173,753,000 |
| Total Debt Most Recent Quarter | 174,966,000 |
| Equity to Debt Ratio Past Year | -0.24 |
| Equity to Debt Ratio Most Recent Quarter | -0.19 |
| Total Stockholder Equity Past Year | -33,651,000 |
| Total Stockholder Equity Prior Year | -33,973,000 |
| Total Stockholder Equity Most Recent Quarter | -28,453,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -23,698,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.16 |
| Free Cash Flow Past Year | -24,235,000 |
| Free Cash Flow Prior Year | -60,334,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.05 |
| MACD Signal | 0.06 |
| 20-Day Bollinger Lower Band | 1.42 |
| 20-Day Bollinger Middle Band | 2.00 |
| 20-Day Bollinger Upper Band | 2.59 |
| Beta | 1.33 |
| RSI | 47.34 |
| 50-Day SMA | 2.14 |
| 150-Day SMA | 2.31 |
| 200-Day SMA | 3.80 |
System |
|
| Modified | 5/13/2025 1:58:41 AM EST |